Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-96-007622
Filing Date
1996-12-30
Accepted
1996-12-30 00:00:00
Documents
8
Period of Report
1996-09-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 191471
2 1993 INCENTIVE AND NON-QUALIFIED STOCK OPTION PLAN EX-10.3 24795
3 EMPLOYMENT AGREEMENT EX-10.5 33512
4 EMPLOYMENT AGREEMENT DATED AUGUST 27, 1991 EX-10.6 23275
5 AGREEMENT DATED SEPTEMBER 27, 1996 EX-10.9 40800
6 SUBSIDIARIES OF THE COMPANY EX-21 311
7 CONSENT OF KPMG PEAT MARWICK, LLP EX-23 1027
8 FINANCIAL DATA SCHEDULE EX-27 2150
  Complete submission text file 0000950123-96-007622.txt   319555
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
ONCOGENE SCIENCE INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-15190 | Film No.: 96687604
SIC: 2835 In Vitro & In Vivo Diagnostic Substances